Researchers have determined that children and adults with cancer usually have different mutated genes driving their disease, which suggests they would likely benefit from different therapies. The finding, from a collaborative study led by St. Jude Children’s Research Hospital, underscores the need to develop precision medicines for pediatric cancer. The research, along with a companion…
Triple-Drug Chemotherapy With Topotecan Helps Preserve Vision in Retinoblastoma Patients
Revamping front-line multi-drug chemotherapy for retinoblastoma to include topotecan helped to maintain high cure rates for the eye cancer while preserving patients’ vision and reducing their risk of treatment-related leukemia. Results of the St. Jude Children’s Research Hospital study appear online in the Journal of Clinical Oncology. “This 10-year follow-up study shows for the first time that…